Orchid Pharma Limited
ORCHPHARMA · NSE · ₹990 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Orchid Pharma Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 75.9%; Net profit was ₹3.22 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹304 cr | +75.9% | Net profit: ₹3 cr | -78.4% | 1.1% | Company filing source |
| Mar 2026 | Revenue: ₹368 cr | +55.1% | Net profit: ₹26 cr | +15.9% | 7.0% | Company filing source |
| Dec 2025 | Revenue: ₹207 cr | — | Net profit: ₹-13 cr | — | -6.1% | Company filing source |
| Sep 2025 | Revenue: ₹194 cr | — | Net profit: ₹-6 cr | — | -3.0% | Company filing source |
| Jun 2025 | Revenue: ₹173 cr | -29.2% | Net profit: ₹15 cr | -49.2% | 8.6% | Company filing source |
| Mar 2025 | Revenue: ₹237 cr | — | Net profit: ₹22 cr | — | 9.4% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Dhanuka Laboratories Limited 69.8%QUANT MUTUAL FUND - QUANT SMALL CAP FUND 6.8%KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK CONSUMPTION FUND AND 7 OTHERS 4.6%UTI SMALL CAP FUND AND 3 OTHERS 3.5%INVESCO INDIA CONTRA FUND AND 2 OTHERS 2.9%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Shareholders meeting. Orchid Pharma Limited has informed the Exchange regarding Proceedings of the 33rd Annual General Meeting held on September 29, 2026…
29 Sep 2026 · document
- Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
28 Sep 2026 · document
- Updates. Orchid Pharma Limited has informed the Exchange regarding 'Trading Approval of Equity Shares issued and allotted under Scheme of Amalgamation'.…
23 Sep 2026 · document
- Updates. Orchid Pharma Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI ( Listing obligation and Disclosure Requirement) Regu…
22 Sep 2026 · document
- Updates. Orchid Pharma Limited has informed the Exchange regarding 'Investor Roadshow Scheduled to be held in Mumbai'.…
21 Sep 2026 · document
- Updates. Orchid Pharma Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.…
07 Sep 2026 · document
- Shareholders meeting. Orchid Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026…
07 Sep 2026 · document
- Change in Management. Orchid Pharma Limited has informed the Exchange about appointment of cost auditor and change in designation of a Director.…
03 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time